Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Tech Wins $750K SBIR Grant for Pathogen Assays

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oligonucleotide-based tools company Biosearch Technologies has reeled in a $750,000 Small Business Innovation Research grant to develop assays for military applications, the company said yesterday.

The Novato, Calif.-based firm plans to use the Phase II SBIR grant from the US Department of Defense to continue development of rapid and accurate assays for detecting pathogens that the military deems important.

The funding covers development of assays for use in testing for rickettsial pathogens, some of which are listed as Category A or B pathogens by the National Institute of Allergy and Infectious Diseases, as well as development of analyte-specific reagents, the company said.

The assays will be based on quantitative polymerase chain reaction (qPCR) technology that has been modified for use in overseas military operations.

“Stable field-deployable reagents for the rapid detection of highly infectious and often lethal pathogens in the field of military operations are of high importance,” Biosearch Technologies’ Director of Research and Development Jerry Ruth said in a statement.

“Such reagents will also be useful in determining the environmental source of each pathogen,” Ruth added.

The company also recently was awarded another Phase II SBIR grant from DoD to design and develop assays for six arbovirus pathogens.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.